In this episode of the Applied Clinical Trials Podcast, C.K. Wang, MD, chief medical officer at COTA; and Sujay Jadhav, CEO ...

“Designing treatments unique to individual patients has always been the promised goal of personalized medicine. After 25 ...

In today’s ACT Brief, we explore how Bayesian trial designs are gaining traction in rare disease research, what priorities ...

At SCOPE Summit 2026, site leaders shared how AI is transforming feasibility, patient identification, and enrollment ...

Jonathan Andrus, co-CEO of CRIO, discusses how increased reliance on site-based technologies and eSource is strengthening ...

Jonathan Andrus, co-CEO of CRIO, explains how protocol-driven eSource templates and standardized data capture are improving ...

Andrus: The biggest risk is fragmented, disconnected data collection across sites. If you think about a large phase 3 trial ...

In today’s ACT Brief, we examine how protocol-driven eSource is reshaping data capture at sites, how digital protocols and ...

In today’s ACT Brief, we examine how site-level data capture is becoming central to trial execution, how Merck and Mayo ...

Angela Zubel, chief development officer, Debiopharm, explains how AI-enabled site selection, patient allocation, and ...

In today’s ACT Brief, we examine how predictive analytics are shaping portfolio decisions, how industry collaboration is ...

As clinical development grows more complex, sponsors are rethinking how outsourcing models, technology, and partnerships ...